Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug
|
March 28, 2025
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic Dermatitis
Yan Zhao, Litao Zhang, Liming Wu, et al.
International Journal of Dermatology
|
November 22, 2025
Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis
Yan Zhao, Litao Zhang, Liming Wu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 15, 2023
Nail psoriasis in China: A prospective multicentre study
Shiqi Wang, Jianjian Zhu, Ping Wang, et al.
Advances in Therapy
|
July 12, 2025
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
Clinical and Translational Allergy
|
November 19, 2025
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
The Journal of Dermatological Treatment
|
July 6, 2026
Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
The British Journal of Dermatology
|
November 29, 2025
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial
Duoqin Wang, Jiyuan Wu, Qing Guo, et al.
Experimental Dermatology
|
June 19, 2026
Serum DSDNA is Associated With Psoriasis
Qi Zhen, Na Yin, Weiwei Chen, et al.
International Immunopharmacology
|
September 26, 2024
Serum dsDNA is environmentally contingent
Qi Zhen, Weiwei Chen, Yang Han, et al.
The Journal of Dermatological Treatment
|
July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials
Yan Zhao, Furen Zhang, Bin Yang, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Dermatitis : Contact, Atopic, Occupational, Drug
|
March 28, 2025
Long-Term Stapokibart Treatment Induces Sustained Clinical Improvements in Patients With Moderate-to-Severe Atopic Dermatitis
Yan Zhao, Litao Zhang, Liming Wu, et al.
International Journal of Dermatology
|
November 22, 2025
Efficacy and Safety of Anti-IL-4Rα Stapokibart in Elderly Patients With Moderate-To-Severe Atopic Dermatitis
Yan Zhao, Litao Zhang, Liming Wu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 15, 2023
Nail psoriasis in China: A prospective multicentre study
Shiqi Wang, Jianjian Zhu, Ping Wang, et al.
Advances in Therapy
|
July 12, 2025
Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis Treated with Stapokibart over 52 weeks: A Post Hoc Analysis of a Phase 3 Trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
Clinical and Translational Allergy
|
November 19, 2025
Efficacy and Safety of Stapokibart in Adults With Moderate-to-Severe Atopic Dermatitis With and Without Type 2 Comorbidities: A Post Hoc Analysis of a Phase 3 Trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
The Journal of Dermatological Treatment
|
July 6, 2026
Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial
Yan Zhao, Litao Zhang, Liming Wu, et al.
The British Journal of Dermatology
|
November 29, 2025
Ivarmacitinib ointment for the treatment of adults with mild-to-moderate atopic dermatitis: phase 3 part of a randomized, double-blind, placebo-controlled, phase 2/3 clinical trial
Duoqin Wang, Jiyuan Wu, Qing Guo, et al.
Experimental Dermatology
|
June 19, 2026
Serum DSDNA is Associated With Psoriasis
Qi Zhen, Na Yin, Weiwei Chen, et al.
International Immunopharmacology
|
September 26, 2024
Serum dsDNA is environmentally contingent
Qi Zhen, Weiwei Chen, Yang Han, et al.
The Journal of Dermatological Treatment
|
July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials
Yan Zhao, Furen Zhang, Bin Yang, et al.
Page
of 6